{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Ardent Health, Inc.
Is Ardent Health, Inc. overvalued or undervalued?
As of October 17, 2025, Ardent Health, Inc. is considered overvalued with a current price of $14.63, significantly higher than its 52-week low of $10.10, and has underperformed the S&P 500 with a return of -24.97% compared to the index's 14.08%.
Is Ardent Health, Inc. overvalued or undervalued?
As of October 17, 2025, Ardent Health, Inc. is considered overvalued with a price of 14.63, reflecting a shift from attractive to expensive, and has underperformed the market with a year-to-date return of -14.34% compared to the S&P 500's 13.30%.
Is Ardent Health, Inc. overvalued or undervalued?
As of October 17, 2025, Ardent Health, Inc. is considered overvalued with a price of 14.63, a significant decline of 24.97% over the past year, and underperformance compared to the S&P 500, which has gained 14.08%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
